New HRT review disappoints on breast cancer risk, says women's health expert
Experts presenting their review of hormone replacement studies at the World Congress on the Menopause in Madrid, Spain, recommended that HRT for women in early menopause is safe after all. Yet, comments Marilyn Glenville, a UK authority on natural health for women, their findings relating to the 50-59 age group acknowledge that there is still an increase in breast cancer risk associated with taking HRT.
Dr Glenville, President for the Food & Health Forum at The Royal Society of Medicine, is author of one of complementary medicines retailer The Nutri Center's best selling health books, The New Natural Alternatives to HRT, which looks at how to stay healthy through the menopause and prevent osteoporosis.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze